Acetyl octapeptide-3

Known published concerns and unanswered questions are kept separate so absence of evidence is never presented as reassurance.

Form describes the specific product; route describes how it reaches the body. These are sourced descriptions, not instructions.

Topical use is the ordinary cosmetic context. A studied cosmetic microneedle patch is not evidence for an injectable drug route.

Status applies to a product, formulation, route, population, and use. It does not apply to a name in the abstract.

1. Jul 22, 2026

   Cosmetic / topical

   Acetyl octapeptide-3 is catalogued as a substance and used in cosmetics, which generally do not receive FDA premarket approval. No FDA-approved drug containing it was identified.

   Specific form or route not separately published in this record.View source

Organize a conversation with a qualified professional without creating a treatment recommendation, dose, or protocol.

• EvidenceWhich human evidence applies to the exact product, form, route, and use being discussed?
• What remains uncertainWhat is known, and what remains uncertain for this specific context?
• RisksWhich important warnings, common effects, and product-quality concerns should be discussed?
• U.S. statusWhat does the U.S. status cover, and what does it not cover?

These profiles share a topic, pathway, product context, or research question. Related does not mean equivalent.

• Acetyl hexapeptide-8Both are topical cosmetic peptides studied in formulation-specific anti-wrinkle contexts.

1. 1

   FDA GSRS record for acetyl octapeptide-3

   U.S. Food and Drug Administration Global Substance Registration System. Acetyl octapeptide-3 substance record.

   U.S. Food and Drug Administration · Accessed Jul 22, 2026 · Regulatory source

   Open source
2. 2

   Clinical study of a multi-ingredient microneedle patch containing acetyl octapeptide-3

   Shin JY, et al. Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities. Annals of Dermatology. 2024;36(4).

   PubMed-indexed primary study · Published Aug 1, 2024 · Accessed Jul 22, 2026 · Clinical study

   Open source
3. 3

   FDA authority over cosmetics

   U.S. Food and Drug Administration. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated.

   U.S. Food and Drug Administration · Published Dec 20, 2022 · Accessed Jul 22, 2026 · Regulatory source

   Open source